QuickView for TNRC13;jsessionid=3D765BD25ABDC6EF1EDE0A75B9F1BD6C;jsessionid=A8AB09FA390A3AE4E0D1D6F38BF237B8;jsessionid=51586F57457820B19218871CCD1B1B0A;jsessionid=1378266A38B81A4711AC8DCC93F77B7F;jsessionid=4528C92532BBC80F364C5724FB5F46CA;jsessionid=51B5E97F111A399A1B0B7ED103AD21F5;jsessionid=FDFCFF2CB78E0831AC4F8DBE8E449E94;jsessionid=2E9B092BD9A88BC66EE05C86D39FFAFD (gene)

1. Ataxin-2 sequesters Raptor into aggregates and impairs cellular mTORC1 signaling.
2. ATXN2 is a target of N-terminal proteolysis.
3. A Case of Coexistent Spinocerebellar Ataxia Type 2 and Primary Progressive Multiple Sclerosis-Coinci…
4. ATXN2 intermediate expansions in amyotrophic lateral sclerosis.
5. TDP-43 impairs sleep in Drosophila through Ataxin-2-dependent metabolic disturbance.

There were no clinical trials for TNRC13;jsessionid=3D765BD25ABDC6EF1EDE0A75B9F1BD6C;jsessionid=A8AB09FA390A3AE4E0D1D6F38BF237B8;jsessionid=51586F57457820B19218871CCD1B1B0A;jsessionid=1378266A38B81A4711AC8DCC93F77B7F;jsessionid=4528C92532BBC80F364C5724FB5F46CA;jsessionid=51B5E97F111A399A1B0B7ED103AD21F5;jsessionid=FDFCFF2CB78E0831AC4F8DBE8E449E94;jsessionid=2E9B092BD9A88BC66EE05C86D39FFAFD